| Autor: |
Satre DD; Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, 8785University of California, San Francisco, CA, USA.; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA., Meacham MC; Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, 8785University of California, San Francisco, CA, USA., Asarnow LD; Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, 8785University of California, San Francisco, CA, USA., Fisher WS; Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, 8785University of California, San Francisco, CA, USA., Fortuna LR; Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, 8785University of California, San Francisco, CA, USA., Iturralde E; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA. |
| Abstrakt: |
The COVID-19 pandemic has heightened concerns about the impact of depression, anxiety, alcohol, and drug use on public health. Mobile apps to address these problems were increasingly popular even before the pandemic, and may help reach people who otherwise have limited treatment access. In this review, we describe pandemic-related substance use and mental health problems, the growing evidence for mobile app efficacy, how health systems can integrate apps into patient care, and future research directions. If equity in access and effective implementation can be addressed, mobile apps are likely to play an important role in mental health and substance use disorder treatment. |
